IP Library Granted Patent US 8,574,253
Granted Patent B2
US 8,574,253 · App. 12/098,250 · Granted Nov 5, 2013

Method, system and device for tissue removal

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,574,253
App. No.
12/098,250
Granted
Nov 5, 2013
Kind
B2
Abstract

A method and device for tissue removal. The device may be used to remove uterine fibroids and other abnormal gynecological tissue. According to one embodiment, the device includes a housing, an outer tube, and an inner tube. The outer tube is fixed to the housing and includes a side window proximate to its distal end. The side window may have sloped proximal and distal ends. The inner tube has a distal end positioned within the outer tube, the distal end being adapted to rotate and, at the same time, to move back and forth past the side window, with the rotational and translational movement of the inner tube being independently controllable. The distal end of the inner tube may have an external bevel. Suction is applied to the proximal end of the inner tube to draw tissue into the side window and to remove resected tissue through the inner tube.

Claims (17)

1. A uterine fibroid tissue removal device, comprising:

an elongate outer tubular member having an outside diameter of no more than about 3.5 mm, the outer tubular member including a tissue receiving side window configured to receive uterine fibroid tissue to be severed from a uterus wall;

an inner tubular member positioned within the outer tubular member, the inner tubular member comprising a proximal end, an open distal end, and a tissue aspiration lumen extending therebetween;

a translational drive configured to oscillate the inner tubular member translationally along a longitudinal axis of the inner tubular member, such that the open distal end of the inner tubular member oscillates translationally across the tissue receiving side window of the outer tubular member to thereby sever uterine fibroid tissue extending therethrough; and

a rotational drive that rotates the inner tubular member at a rate of at least 5000 revolutions per minute about the longitudinal axis of the inner tubular member while the inner tubular member oscillates translationally across the tissue receiving side window, such that the device is capable of removing uterine fibroid tissue severed by the inner tubular member at a rate of at least about 1.8 gm/min.

2. The tissue removal device of claim 1 , wherein

the rotational drive comprises a rotational driving mechanism mechanically coupling a first drive shaft to the inner tubular member to transfer rotational energy from the first drive shaft to the inner tubular member to thereby rotate the inner tubular member about the longitudinal axis of the inner tubular member; and wherein

the translational drive comprises an oscillating translational driving mechanism mechanically coupling a second drive shaft to the inner tubular member to transfer translating energy from the second drive shaft to the inner tubular member to thereby oscillate translationally the inner tubular member along the longitudinal axis of the inner tubular member.

3. The tissue removal device of claim 1 , further comprising a vacuum source in communication with the tissue aspiration lumen of the inner tubular member.

4. The tissue removal device of claim 1 , wherein at least a portion of the outer tubular member is flexible.

5. The tissue removal device of claim 4 , wherein at least a portion of the inner tubular member is flexible.

6. The tissue removal device of claim 1 , further comprising a housing coupled to the outer tubular member.

7. The tissue removal device of claim 6 , wherein the outer tubular member is coupled to the housing in a non-coaxial manner.

8. The tissue removal device of claim 1 , wherein the rotational drive rotates the inner tubular member at a rate of approximately 6000 revolutions per minute, and the translational drive is configured to translationally oscillate the inner tubular member at a rate of approximately 240 cycles per minute.

9. The tissue removal device of claim 8 , wherein an advance ratio equal to a ratio of the rate of oscillation to the rate of rotation of the inner tubular member is less than 0.25.

10. The tissue removal device of claim 1 , wherein the open distal end of the inner tubular member has an external bevel.

11. The tissue removal device of claim 1 , wherein the tissue receiving side window on the outer tubular member has sloped or jagged distal and proximal ends.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →